哮喘临床试验招募信息（全球在招）

这里汇总了全球正在招募患者的 哮喘（国际通用名 asthma）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。

正在招募的哮喘新药试验

• Investigation of Fixed Triple Inhaled Combination in Asthmatic Patients, in a Real-life Setting

  不适用招募中HungaryNCT06678191

• Expressions of Ezrin and Pip5k1α Proteins in Airway Smooth Muscle of Asthmatic Patients

  不适用招募中中国NCT06427018

• Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients

  II 期招募中中国NCT07342803

• Real-World Effectiveness of Benralizumab in Allergic Bronchopulmonary Aspergillosis

  不适用招募中中国NCT07530770

• Asthma Crisis in Paediatrics: Impact of a Care Pathway in Primary and Hospital Care

  不适用招募中西班牙NCT06437444

• Role of Genetic Factors in the Development of Lung Disease

  不适用招募中美国NCT00001532

• Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

  III 期招募中美国中国MexicoSouth AfricaNCT06307665

• Residual Exacerbations With Mepolizumab

  不适用招募中加拿大NCT04578171

• A Randomised Feasibility Study of CPAP in Large Airway Collapse

  不适用招募中英国NCT07504926

• Metformin IN Asthma for Overweight and Obese Individuals (MINA)

  II 期招募中美国NCT06273072

• A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)

  III 期招募中美国Argentina澳大利亚BelgiumNCT07359846

• Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment

  III 期招募中美国ArgentinaAustriaBelgiumNCT07444567